ADHD in the News 2023-01-12
ADHD Drug Shortages Spread to Generic Ritalin
Shortages of ADHD medications that started this summer with Adderall have widened to now include another major category of stimulants. For the past two months, patients have had a hard time finding methylphenidate drugs, a class that includes Novartis AG’s Ritalin and Johnson & Johnson’s Concerta. A drug manufacturer and a major pharmacy told Bloomberg News there are issues with the supply of the drugs, though it’s unclear what’s causing the shortage.
fMRI Neurofeedback Ineffective in Improving Pediatric ADHD Symptoms
Functional MRI neurofeedback (fMRI-NF) may be ineffective in improving clinical symptoms or cognition in boys with attention-deficit/hyperactivity disorder (ADHD), according to a recent double-blind, sham-controlled randomized controlled trial. Researchers published their results in The American Journal of Psychiatry.
Inflammation Influences the Link Between Sleep and ADHD
The potential mediating role of inflammation at 9 years, measured by CRP and IL-6, was investigated in the relationship between sleep and ADHD.
Childhood Maltreatment Linked With Multiple Mental Health Problems
Summary: Researchers have identified a causal effect between childhood maltreatment and an increased risk of mental health disorders.
How wearable, trackable tech makes driving safer for teens with ADHD
Technology developed by researchers in the UNC STAR Heel Performance Laboratory provided real-time feedback for teens during a study aimed at decreasing the risk of traffic crashes.
Inflow, a platform for managing ADHD through cognitive behavioral therapy, raises $11M
Inflow, a company developing a platform to manage ADHD using cognitive behavioural therapy (CBT) techniques, has raised $11 million in a Series A round of funding. ADHD, or “attention deficit hyperactivity disorder,” is a condition impacting as much as 10% of the global population. Symptoms vary, but typically involve inattention, hyperactivity, anxiety and impulsivity.
Behavioral Telehealth Loses Momentum Without a Regulatory Boost
Controlled substances became a little less controlled during the pandemic. That benefited both patients (for their health) and telehealth startups (to make money). Some potentially addictive medications — like buprenorphine and Adderall — are now far more available online to patients because of regulatory changes.
Developmental disorders tied to more allergic disease
Elementary school-age children with developmental disorders are more likely to have allergic diseases, according to a study published in the January issue of Pediatrics International.
The Effectiveness of DBT-bGT Compared to Treatment as Usual for ADHD Adults
The following is a summary of the “Dialectical behavioral therapy-based group treatment versus treatment as usual for adults with attention-deficit hyperactivity disorder: a multicenter randomized controlled trial” published in the November 2022 issue of Psychiatry by Halmøy et al. Studies on structured skills training groups have revealed favorable, although still unclear, effects on core symptoms of Attention Deficit Hyperactivity Disorder(ADHD) in adults.
Misattributing Learning Disorder Symptoms to Psychopathology: The need for a comprehensive neuropsychological or psychoeducational assessment.
KEY POINTS: Misattribution of "hidden disabilities" can be prevented. Comprehensive neuropsychological assessment can help distinguish between psychological and neurological issues that produce similar behaviors. An accurate diagnosis is needed to provide treatment that properly addresses the actual issues at hand. Assessments are also necessary to determine eligibility for accommodations.
How To Curb Food Waste When You Have ADHD
For people with ADHD, traditional suggestions on how to waste less food tend to backfire. Here are expert-backed strategies that may jive better with your brain.
What are ‘masking’ and ‘camouflaging’ in the context of autism and ADHD?
Many autistic people and ADHD-ers report using “masking” and “camouflaging” in their lives. This is where people conceal certain traits and replace them with neurotypical ones to avoid being recognised as neurominorities.